0.4440
+0.0460
+(11.56%)
As of 5:58:53 PM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| J90.F | -- | -- | -- | -- |
| S&P 500 | 13.90% | 7.87% | 13.12% | 14.10% |
Related Tickers
PHPN.F Galectin Therapeutics Inc.
1.2300
0.00%
6Y4.F Vicore Pharma Holding AB (publ)
0.7310
-2.14%
CRO.F hVIVO plc
0.1900
-0.52%
6XY.F HBM Holdings Limited
0.4700
-6.93%
1U5.F Wave Life Sciences Ltd.
10.20
+4.62%
6K9.F Context Therapeutics Inc.
0.7300
+2.10%
HQ1.MU Oruka Therapeutics Inc. R
11.20
+3.70%
REGN.MX Regeneron Pharmaceuticals, Inc.
13,757.24
+0.80%
8F8.SG SynAct Pharma AB
1.3460
-1.68%
ICY.SG Incyte Corp
65.98
+0.03%